Decoding Protein Complexity: The Fundamental Role of Post-Translational Modifications in Cellular Function and Disease
Authors: Henning Boekhoff, Jana S. Röder
Proteins are key players in cellular functions. They are encoded by their corresponding genes, but protein functions and activity are remarkably diverse and dynamic, largely due to post-translational modifications (PTMs). PTMs are covalent chemical changes to the side chains of amino acids that occur after protein synthesis, enhancing protein diversity across life forms from Archaea to Eukaryotes. This mechanism complements the complex network of proteomic regulation, greatly expanding upon gene expression, gene duplication, and alternative splicing. While the genome acts as a blueprint, providing the necessary information to build a functioning cell, the proteome is a complex structure that vastly extends beyond the blueprint’s scope.
Protein functions and activity are remarkably diverse and dynamic, largely due to post-translational modifications (PTMs). PTMs are covalent chemical changes to the side chains of amino acids that occur after protein synthesis, enhancing protein diversity across life forms from Archaea to Eukaryotes. This mechanism complements the complex network of proteomic regulation, greatly expanding upon gene expression, gene duplication, and alternative splicing.
Read more ...
From Discovery to Clinical Application: The Role of Biomarkers in Precision Medicine
Authors: Jana S. Röder, Henning Boekhoff
Biomarkers for Precision Medicine: Shaping Diagnostics and Medical Care
Modern medicine relies on precise diagnostics and reliable patient stratification to provide the best possible patient care. However, most diseases are still defined by symptom descriptions and selecting the best treatment option can be a trial-and-error approach. This places a burden on patients and healthcare systems, as treatments are often not as effective and as adapted to the disease as they should be. This can lead to undertreatment of certain patient subpopulations and even to adverse events without treatment benefit. Precision medicine aims to change this by using molecular mechanisms for disease definition and treatment selection.
Discovery: Early Biomarkers Predict Severe COVID-19
Authors: Henning Boekhoff, Jana S. Röder
Biomarker Discovery for Predicting Dengue Deterioration: A Breakthrough Study
Authors: Jana S. Röder, Henning Boekhoff
Dengue is caused by the dengue virus (DENV), which is transmitted by multiple Aedes mosquito species. The disease has spread globally due to globalization, but infections are currently most common in tropical and subtropical regions. Endemic transmission of the dengue virus is mainly reported in the Eastern Mediterranean, the Americas, Southeast Asia, the Western Pacific, and Africa. However, transmissions have also been reported in Europe and the United States. In 2023, the World Health Organization (WHO) reported a near historic peak of dengue cases: there were over five million cases and more than 5000 dengue-related deaths. Close to 80 % of these cases, or 4.1 million, have been reported in the region of the Americas. The WHO states that the actual disease burden is likely higher, due to under-reporting of infections. It is estimated that more than half of the world’s population lives in areas affected by dengue virus. Dengue is a global threat.
Dengue is a disease caused by dengue virus (DENV), which is transmitted by Aedes species. Dengue is a global threat. Simple and inexpensive strategies for the identification of patients with severe or life-threatening illness are urgently needed.
Testimonials
Tara Sigdel, PhD
Associate Professor, Department of Surgery, University of California San Francisco
"We collaborated with Sciomics GmbH in Germany to analyze proteomics data from blood samples of kidney transplant recipients and liver perfusates during normothermic machine perfusion. Throughout the process, Sciomics provided exceptional support, ensuring timely data delivery and valuable assistance with data analysis. Their expertise and commitment have been instrumental in advancing our research, and we are currently using their data in multiple manuscript submissions. I highly recommend Sciomics for their reliable service and expertise in proteomics."
Product: scioDiscover
Dr. Matthew Wright
Chief Scientific Officer, Kinarus Therapeutics AG, Basel, Switzerland
"We are a small biotech company without our own wet labs. Sciomics recommended a UK CRO that performed cell culture experiments for our studies. Sciomics seamlessly coordinated the transfer of the biologic materials to their facility and performed the scioCD panel to characterize cell surface markers and cytokines in cell lines treated with our small molecule drug candidates. The Sciomics data were instrumental in supporting our IP protection strategy. Their advice was very helpful and they worked with us to extract the most out of the data. We are very satisfied and highly recommend the Sciomics platform and the team."
Product: scioCD